Core Viewpoint - Zhongjin Irradiation (300962.SZ) announced a plan to issue A-shares to specific investors, aiming to raise up to RMB 800 million for various sterilization projects and working capital [1][2]. Group 1: Fundraising Details - The total amount to be raised is capped at RMB 80,000,000, which will be used for projects including the Changsha Sterilization Technology Service Center and the Hefei Comprehensive Sterilization Technology Center [1]. - The issuance will target no more than 35 specific investors, including China National Gold Group, which will subscribe RMB 10,000,000 worth of shares [1]. - The number of shares issued will not exceed 30% of the total share capital prior to the issuance, amounting to a maximum of 79,200,569 shares [1]. Group 2: Pricing and Financial Performance - The issuance will adopt a bidding method, with the price set at no less than 80% of the average trading price over the 20 trading days prior to the pricing date or the higher of the latest audited net asset value per share [2]. - For the first three quarters of 2025, Zhongjin Irradiation reported revenue of RMB 278 million, a year-on-year increase of 2.33%, while net profit attributable to shareholders decreased by 6.35% to RMB 89.81 million [2]. - The net profit excluding non-recurring gains and losses was RMB 78.99 million, down 15.35% year-on-year, with net cash flow from operating activities at RMB 130 million [2].
中金辐照拟定增募资不超8亿元 2021年上市募资2.24亿